Global Smallpox Treatment Market 2022-2026

Description

List of Tables

Technavio has been monitoring the smallpox treatment market and it is poised to grow by $ 66.1 mn during 2022-2026, accelerating at a CAGR of 1.76% during the forecast period. Our report on the smallpox treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing stockpiling of smallpox therapeutics, increasing drug approvals, and increasing contract manufacturing practices.

The smallpox treatment market analysis includes the product segment and geographic landscape.

Technavio's smallpox treatment market is segmented as below:

By Product

Drugs
Vaccines

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing efforts by vendors as one of the prime reasons driving the smallpox treatment market growth during the next few years. Also, the growing threat of bioterrorism and expedited approvals will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on smallpox treatment market covers the following areas:

Smallpox treatment market sizing
Smallpox treatment market forecast
Smallpox treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading smallpox treatment market vendors that include Bavarian Nordic AS, Chimerix Inc., Emergent BioSolutions Inc., EpiVax Inc., Gilead Sciences Inc., KM Biologics Co. Ltd., Marker Therapeutics Inc., Nano Therapeutics Pvt. Ltd., Oncovir Inc., Pfizer Inc., Symphogen, Tonix Pharmaceuticals Holding, SIGA Technologies Inc., and Cel Sci Corp. Also, the smallpox treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73240

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Drugs - Market size and forecast 2021-2026
Exhibit 28: Chart on Drugs - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Drugs - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Drugs - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Drugs - Year-over-year growth 2021-2026 (%)
5.4 Vaccines - Market size and forecast 2021-2026
Exhibit 32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Product
Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 India - Market size and forecast 2021-2026
Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Bavarian Nordic AS
Exhibit 89: Bavarian Nordic AS - Overview
Exhibit 90: Bavarian Nordic AS - Product / Service
Exhibit 91: Bavarian Nordic AS - Key news
Exhibit 92: Bavarian Nordic AS - Key offerings
10.4 Cel Sci Corp.
Exhibit 93: Cel Sci Corp. - Overview
Exhibit 94: Cel Sci Corp. - Product / Service
Exhibit 95: Cel Sci Corp. - Key offerings
10.5 Chimerix Inc.
Exhibit 96: Chimerix Inc. - Overview
Exhibit 97: Chimerix Inc. - Product / Service
Exhibit 98: Chimerix Inc. - Key offerings
10.6 Emergent BioSolutions Inc.
Exhibit 99: Emergent BioSolutions Inc. - Overview
Exhibit 100: Emergent BioSolutions Inc. - Product / Service
Exhibit 101: Emergent BioSolutions Inc. - Key news
Exhibit 102: Emergent BioSolutions Inc. - Key offerings
10.7 EpiVax Inc.
Exhibit 103: EpiVax Inc. - Overview
Exhibit 104: EpiVax Inc. - Product / Service
Exhibit 105: EpiVax Inc. - Key offerings
10.8 Gilead Sciences Inc.
Exhibit 106: Gilead Sciences Inc. - Overview
Exhibit 107: Gilead Sciences Inc. - Product / Service
Exhibit 108: Gilead Sciences Inc. - Key news
Exhibit 109: Gilead Sciences Inc. - Key offerings
10.9 KM Biologics Co. Ltd.
Exhibit 110: KM Biologics Co. Ltd. - Overview
Exhibit 111: KM Biologics Co. Ltd. - Product / Service
Exhibit 112: KM Biologics Co. Ltd. - Key offerings
10.10 Nano Therapeutics Pvt. Ltd.
Exhibit 113: Nano Therapeutics Pvt. Ltd. - Overview
Exhibit 114: Nano Therapeutics Pvt. Ltd. - Key offerings
10.11 Pfizer Inc.
Exhibit 115: Pfizer Inc. - Overview
Exhibit 116: Pfizer Inc. - Product / Service
Exhibit 117: Pfizer Inc. - Key news
Exhibit 118: Pfizer Inc. - Key offerings
10.12 SIGA Technologies Inc.
Exhibit 119: SIGA Technologies Inc. - Overview
Exhibit 120: SIGA Technologies Inc. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 121: Inclusions checklist
Exhibit 122: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 123: Currency conversion rates for US$
11.4 Research methodology
Exhibit 124: Research methodology
Exhibit 125: Validation techniques employed for market sizing
Exhibit 126: Information sources
11.5 List of abbreviations
Exhibit 127: List of abbreviations